← Eichor
Study identifier: NCT04868305 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures

Condition: Hip Injuries and Disorders · Hip Fractures  ·  Sponsor: Helse Stavanger HF

PhaseNA
Planned participants170
Who can joinAll sexes, 65 Years to 120 Years
Healthy volunteersNo

About this study

A hip fracture is a large burden to the patient with increased mortality, pain and increased need for daily assistance. Trochanteric fractures of the femur (FTF) represents about 35% of the hip fractures. Today FTFs are mainly treated with internal fixation using sliding hips screws (SHS) or intramedullary nail (IMN), whilst hip arthroplasty (THA/HA) is rarely used. Despite advances in the design of the internal fixation implants there is a high failure rate, in particular in cases of FTFs classified as unstable fractures. Since the introduction of hip arthroplasty in femoral neck fractures there has been a reduction in complication rates, early mobilization and shorter hospital stays. The primary objective of this project is to investigate if treatment with hip arthroplasty in unstable FTFs will increase the postoperative mobility, give a better general health outcome for the patient, better quality of life and reduce re-operation rate for the patients compared to those operated with the traditional IMN.

This description comes directly from the study's public registry record.

Talk to the study team

Thomas Abel Woldeyesus, MD  ·  +4751513488  ·  thomas.abel.woldeyesus@sus.no

Ane Djuv, MD., PhD  ·  +4751518284  ·  ane.djuv@sus.no

Always discuss trial participation with your own doctor first.

Locations (1)

Stavanger University HospitalStavanger, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04868305